Abstract
Stroke is a major cause of disability and cognitive impairment, accounting for 5.2% deaths worldwide. Antiplatelets and anticoagulants have been widely used as prevention of recurrent stroke. Recently, lumbrokinase has been used in stroke and other cardiovascular patients, but further research is needed.
Cite
CITATION STYLE
APA
Mardiono, M. M. L. (2024). Peran Lumbrokinase pada Tata Laksana Stroke Iskemik. Cermin Dunia Kedokteran, 51(2), 95–98. https://doi.org/10.55175/cdk.v51i2.1021
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free